These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38787329)
1. Studies on Methylpyrazole-Substituted Benzimidazoles to Target Dilip H; Thiruvenkatam V; Kirubakaran S ACS Infect Dis; 2024 Jun; 10(6):2262-2275. PubMed ID: 38787329 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and In Vitro Enzymatic Studies of New 3-Aryldiazenyl Indoles as Promising Helicobacter pylori IMPDH Inhibitors. Jangra S; Purushothaman G; Juvale K; Ravi S; Menon A; Thiruvenkatam V; Kirubakaran S Curr Top Med Chem; 2019; 19(5):376-382. PubMed ID: 30827248 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2. Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298 [TBL] [Abstract][Full Text] [Related]
5. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors. Galal AMF; Mohamed HS; Abdel-Aziz MM; Hanna AG Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000385. PubMed ID: 33576040 [TBL] [Abstract][Full Text] [Related]
6. Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection. Juvale K; Purushothaman G; Singh V; Shaik A; Ravi S; Thiruvenkatam V; Kirubakaran S Sci Rep; 2019 Jan; 9(1):190. PubMed ID: 30655593 [TBL] [Abstract][Full Text] [Related]
7. Mutants of Helicobacter pylori IMPDH: Kinetics and in silico Studies to Determine the Structural and Functional Role of Key Amino Acids. Dilip H; Purushothaman G; Sharma G; Menon A; Thiruvenkatam V; Kirubakaran S Chem Asian J; 2022 May; 17(9):e202200125. PubMed ID: 35293683 [TBL] [Abstract][Full Text] [Related]
8. Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential. Abdel-Baki PM; El-Sherei MM; Khaleel AE; Abdel-Aziz MM; Okba MM Sci Rep; 2022 Jul; 12(1):11457. PubMed ID: 35794127 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells. Chang CS; Liu JF; Lin HJ; Lin CD; Tang CH; Lu DY; Sing YT; Chen LY; Kao MC; Kuo SC; Lai CH Eur J Med Chem; 2012 Feb; 48():244-54. PubMed ID: 22217866 [TBL] [Abstract][Full Text] [Related]
10. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780 [TBL] [Abstract][Full Text] [Related]
11. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections. Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280 [TBL] [Abstract][Full Text] [Related]
12. Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials. Ohishi T; Inaoka DK; Kita K; Kawada M Chem Pharm Bull (Tokyo); 2018; 66(3):239-242. PubMed ID: 29491257 [TBL] [Abstract][Full Text] [Related]
13. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori. Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301 [TBL] [Abstract][Full Text] [Related]
14. Insight into the inhibitory effects of Zanthoxylum nitidum against Helicobacter pylori urease and jack bean urease: Kinetics and mechanism. Lu Q; Li C; Wu G J Ethnopharmacol; 2020 Mar; 249():112419. PubMed ID: 31759110 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. Kirubakaran S; Gorla SK; Sharling L; Zhang M; Liu X; Ray SS; Macpherson IS; Striepen B; Hedstrom L; Cuny GD Bioorg Med Chem Lett; 2012 Mar; 22(5):1985-8. PubMed ID: 22310229 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Antimicrobial Evaluation and Molecular Docking of Some Potential 2,6-disubstituted 1H-Benzimidazoles; Non-Classical Antifolates. Harer S; Bhatia M; Kawade V Med Chem; 2019; 15(7):813-832. PubMed ID: 30727904 [TBL] [Abstract][Full Text] [Related]
17. Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori. Tseng YY; Liou JM; Hsu TL; Cheng WC; Wu MS; Wong CH Bioorg Med Chem Lett; 2014 Jun; 24(11):2412-4. PubMed ID: 24775303 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Shah CP; Kharkar PS Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, In Silico Studies, and Evaluation of Syn and Anti Isomers of Kalatuwawege IP; Gunaratna MJ; Udukala DN Molecules; 2021 Nov; 26(21):. PubMed ID: 34771067 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy. Kühler TC; Swanson M; Shcherbuchin V; Larsson H; Mellgârd B; Sjöström JE J Med Chem; 1998 May; 41(11):1777-88. PubMed ID: 9599229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]